Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
MLYS	MINERALYS THERAPEUTICS INC	$2.40B	-27.90%	-27.00%	-23.78%	-38.70%	0.02	44.33	N/A	N/A	N/A
CODX	CO-DIAGNOSTICS INC	$9.83M	-164.90%	-141.20%	-291.20%	-1,036.40%	0.34	2.28	45.10%	-6,753.70%	-6,980.30%
KLRS	KALARIS THERAPEUTICS INC	$110.63M	-72.80%	-43.50%	-43.35%	-155.90%	0.60	12.19	N/A	N/A	N/A
EIKN	EIKON THERAPEUTICS INC	$651.29M	N/A	N/A	N/A	N/A	0.55	11.75	N/A	N/A	N/A
MAIA	MAIA BIOTECHNOLOGY INC	$88.77M	-284.80%	-142.90%	-83.62%	413.60%	0.27	5.59	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$233.33M	-73.20%	-62.70%	-91.58%	-77.10%	0.21	8.16	N/A	N/A	N/A
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$1.92M	N/A	N/A	N/A	N/A	-1.07	0.02	N/A	N/A	N/A
JBIO	JADE BIOSCIENCES INC	$1.05B	-51.30%	-47.30%	-43.59%	-86.20%	0.08	14.29	N/A	N/A	N/A
MDWD	MEDIWOUND LTD	$188.48M	-67.20%	-31.90%	-42.05%	-66.40%	0.93	2.41	19.60%	-180.30%	-169.43%
STRO	SUTRO BIOPHARMA INC	$507.55M	N/A	-69.20%	-89.49%	-154.30%	-4.62	3.12	100.00%	-154.20%	-153.78%
PMVP	PMV PHARMACEUTICALS INC	$64.26M	-69.00%	-62.70%	-89.03%	-103.90%	0.10	11.14	N/A	N/A	N/A
CBUS	CIBUS INC	$107.63M	-225.60%	-31.10%	-21.00%	-23.10%	8.14	2.37	100.00%	-2,366.30%	-1,520.35%
NBP	NOVABRIDGE BIOSCIENCES	$232.03M	-20.90%	-19.40%	-19.80%	-73.60%	0.13	8.09	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$638.24M	N/A	N/A	N/A	N/A	0.03	38.00	N/A	N/A	N/A
ASBP	ASPIRE BIOPHARMA HOLDINGS INC	$7.62M	N/A	-398.00%	-48.57%	89.70%	0.84	2.26	16.30%	-34,039.70%	-5,573.01%
CTEV	CLARITEV CORP	$565.30M	N/A	-5.80%	0.52%	0.50%	-21.04	1.28	73.20%	-29.30%	2.45%
PRAX	PRAXIS PRECISION MEDICINES INC	$8.74B	-43.00%	-40.20%	-23.16%	-71.10%	0.04	15.88	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$187.70M	-80.60%	-65.20%	-70.17%	-170.00%	0.27	5.75	100.00%	-36,891.10%	-36,891.11%
ALVO	ALVOTECH	$1.08B	N/A	-5.70%	17.08%	8.60%	-6.03	1.76	61.50%	-14.40%	35.29%
NTLA	INTELLIA THERAPEUTICS INC	$2.49B	-57.30%	-46.10%	-57.83%	-56.60%	0.22	6.10	100.00%	-597.00%	-597.04%
KLRA	KAILERA THERAPEUTICS INC	$3.02B	N/A	N/A	N/A	N/A	-0.15	9.67	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$150.29M	-154.00%	-105.40%	-128.06%	-867.00%	0.28	1.15	N/A	N/A	N/A
FULC	FULCRUM THERAPEUTICS INC	$247.88M	-27.80%	-26.30%	-22.59%	-38.20%	0.04	34.33	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$1.10B	-29.40%	-27.30%	-23.43%	-90.50%	0.05	24.76	100.00%	-871.80%	-867.09%
FDMT	4D MOLECULAR THERAPEUTICS INC	$664.95M	-36.80%	-32.50%	-34.27%	-39.10%	0.14	9.34	100.00%	-182.30%	-182.34%
DRTS	ALPHA TAU MEDICAL LTD	$1.19B	-57.30%	-42.40%	-44.90%	-44.40%	0.37	7.45	N/A	N/A	N/A
ADCT	ADC THERAPEUTICS SA	$158.99M	N/A	-44.70%	-37.69%	-77.60%	-2.35	4.09	90.70%	-173.00%	-106.58%
SNDA	SONIDA SENIOR LIVING INC	$1.95B	-51.00%	-9.60%	-2.48%	-3.00%	1.96	0.44	22.00%	-30.10%	-13.84%
IMNM	IMMUNOME INC	$2.71B	-51.20%	-47.30%	-37.91%	-669.90%	0.05	21.68	100.00%	-5,593.80%	-5,593.85%
REPL	REPLIMUNE GROUP INC	$962.85M	-128.60%	-82.30%	-111.48%	-110.50%	1.00	4.79	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$74.66M	-127.30%	-34.50%	-47.72%	-32.10%	3.44	1.65	100.00%	-4,088.80%	-4,088.84%
HROW	HARROW INC	$1.67B	-33.70%	-3.90%	3.65%	4.50%	13.63	2.48	74.10%	-5.60%	4.45%
TEM	TEMPUS AI INC	$10.90B	-70.20%	-14.60%	-13.31%	-14.80%	4.13	3.32	63.40%	-22.20%	-17.73%
CTMX	CYTOMX THERAPEUTICS INC	$829.45M	-38.50%	-29.40%	-18.11%	-41.50%	0.12	10.38	100.00%	-174.80%	-165.74%
GLUE	MONTE ROSA THERAPEUTICS INC	$1.96B	-41.00%	-25.90%	-19.82%	-39.40%	0.41	9.54	100.00%	-302.70%	-307.04%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$112.88M	-36.40%	-28.80%	-36.50%	-35.70%	0.27	8.46	N/A	N/A	N/A
CATX	PERSPECTIVE THERAPEUTICS INC	$411.71M	-41.80%	-34.60%	-29.42%	-50.50%	0.18	8.75	100.00%	-17,982.70%	-18,053.88%
ONMD	ONEMEDNET CORP	$38.38M	N/A	-178.70%	85.89%	107.20%	-1.37	0.27	-51.40%	-254.10%	-250.57%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$244.31M	-158.10%	-60.40%	-60.37%	-73.50%	1.21	7.03	99.50%	-167.60%	-160.44%
NGNE	NEUROGENE INC	$514.51M	-37.90%	-34.70%	-40.38%	-52.40%	0.11	13.08	N/A	N/A	N/A
SCLX	SCILEX HOLDING CO	$68.52M	N/A	-164.90%	176.30%	280.10%	-2.16	0.08	59.70%	-1,239.40%	-1,083.57%
ELAB	PMGC HOLDINGS INC	$6.09M	-117.00%	-70.30%	-70.27%	-462.80%	1.07	1.45	32.70%	-873.10%	-813.97%
CLPT	CLEARPOINT NEURO INC	$539.81M	-141.00%	-37.00%	-30.08%	-37.70%	3.96	5.79	62.30%	-71.60%	-62.17%
CRDL	CARDIOL THERAPEUTICS INC	$119.70M	-229.20%	-165.40%	-149.71%	997.90%	0.30	4.39	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$2.40B	-14.90%	-10.60%	-14.11%	-14.50%	0.39	14.05	100.00%	-181.70%	-224.46%
MPLT	MAPLIGHT THERAPEUTICS INC	$1.59B	N/A	N/A	N/A	N/A	0.05	22.91	N/A	N/A	N/A
AKBA	AKEBIA THERAPEUTICS INC	$348.74M	-62.70%	-5.70%	1.24%	5.70%	12.24	1.40	81.00%	-8.80%	1.01%
OGI	ORGANIGRAM GLOBAL INC	$134.97M	-6.80%	-4.60%	-8.99%	-14.40%	0.40	2.82	35.60%	-9.20%	-14.18%
PASG	PASSAGE BIO INC	$15.08M	-150.90%	-59.80%	-230.32%	-270.70%	2.10	1.73	N/A	N/A	N/A
MTVA	METAVIA INC	$7.80M	-172.90%	-89.40%	-142.73%	213.00%	0.59	2.73	N/A	N/A	N/A
AVBP	ARRIVENT BIOPHARMA INC	$1.61B	-49.00%	-45.40%	-44.79%	-68.00%	0.08	13.95	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$16.69M	-67.40%	-34.80%	-58.28%	-62.80%	1.03	0.58	80.10%	-823.30%	-805.20%
EVMN	EVOMMUNE INC	$445.19M	N/A	N/A	N/A	N/A	0.06	20.36	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$6.11B	-23.30%	-22.20%	-16.98%	-24.20%	0.04	31.30	-50.00%	-3,682.60%	-3,682.61%
TRDA	ENTRADA THERAPEUTICS INC	$292.32M	-51.20%	-42.20%	-52.21%	-48.90%	0.24	13.90	100.00%	-2,895.10%	-2,878.29%
EDIT	EDITAS MEDICINE INC	$357.36M	-677.40%	-58.20%	-101.07%	-167.00%	32.88	3.22	100.00%	-281.60%	-286.17%
AMLX	AMYLYX PHARMACEUTICALS INC	$2.00B	-55.70%	-50.70%	-54.05%	-158.90%	0.08	17.85	N/A	N/A	N/A
BCTX	BRIACELL THERAPEUTICS CORP	$30.45M	-155.10%	-130.60%	-134.00%	-411.10%	0.16	7.07	N/A	N/A	N/A
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$2.05M	-408.30%	-138.10%	-306.82%	303.00%	2.53	0.30	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$3.77B	-69.00%	-35.30%	-45.56%	-51.60%	0.90	4.04	100.00%	-156.40%	-152.12%
UNCY	UNICYCIVE THERAPEUTICS INC	$143.11M	-131.20%	-82.30%	-105.20%	2,005.20%	0.71	2.40	N/A	N/A	N/A
ALMS	ALUMIS INC	$3.48B	-54.60%	-43.50%	-40.95%	-67.30%	0.18	7.51	100.00%	-2,825.70%	-2,927.59%
OWLT	OWLET INC	$171.40M	N/A	-62.50%	-111.12%	-369.70%	2.42	1.71	50.90%	-45.30%	-40.08%
PYXS	PYXIS ONCOLOGY INC	$155.85M	-135.60%	-85.00%	-168.21%	-96.30%	1.06	2.76	82.80%	-589.80%	-579.80%
ACTU	ACTUATE THERAPEUTICS INC	$33.50M	-430.90%	-180.90%	-513.59%	372.90%	1.36	1.80	N/A	N/A	N/A
TARA	PROTARA THERAPEUTICS INC	$229.31M	-38.70%	-36.00%	-34.59%	-44.50%	0.06	15.69	N/A	N/A	N/A
MNPR	MONOPAR THERAPEUTICS	$650.61M	-12.80%	-12.60%	-11.06%	-32.20%	0.02	56.05	N/A	N/A	N/A
BEAT	HEARTBEAM INC	$38.36M	-1,034.00%	-434.40%	-3,185.98%	2,184.20%	5.19	0.74	N/A	N/A	N/A
VANI	VIVANI MEDICAL INC	$112.11M	-264.00%	-79.80%	-76.13%	-86.20%	1.22	3.18	N/A	N/A	N/A
EWTX	EDGEWISE THERAPEUTICS INC	$4.31B	-32.50%	-31.00%	-35.49%	-35.10%	0.05	22.61	N/A	N/A	N/A
PVLA	PALVELLA THERAPEUTICS INC	$2.01B	-56.90%	-42.50%	-16.46%	-633.60%	0.14	28.88	N/A	N/A	N/A
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$148.59M	-122.30%	-97.10%	-149.73%	-482.50%	0.41	3.23	100.00%	-27,727.90%	-27,645.92%
WGS	GENEDX HOLDINGS CORP	$2.05B	-27.50%	-15.70%	-17.88%	-28.10%	0.99	3.09	69.60%	-17.60%	-16.91%
GNLX	GENELUX CORP	$135.42M	-174.60%	-123.60%	-133.79%	-207.60%	0.41	3.68	N/A	N/A	N/A
ODTX	ODYSSEY THERAPEUTICS INC	$791.08M	N/A	N/A	N/A	N/A	-0.09	8.33	N/A	N/A	N/A
DMAC	DIAMEDICA THERAPEUTICS INC	$431.61M	-77.20%	-69.30%	-74.22%	-90.40%	0.12	9.11	N/A	N/A	N/A
CGC	CANOPY GROWTH CORP	$405.27M	-39.20%	-25.00%	-27.38%	-34.50%	0.60	3.34	24.50%	-92.40%	-92.37%
ALT	ALTIMMUNE INC	$598.98M	-42.60%	-35.60%	-27.25%	-51.40%	0.18	29.56	100.00%	-253,002.80%	-245,494.44%
EDSA	EDESA BIOTECH INC	$64.11M	-82.30%	-75.40%	-102.41%	1,789.60%	0.22	4.76	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$2.12B	-64.60%	-48.40%	-40.72%	-296.40%	0.26	14.81	87.20%	-558.20%	-535.90%
TMDX	TRANSMEDICS GROUP INC	$2.46B	41.90%	15.80%	7.95%	9.40%	1.90	6.74	59.10%	27.00%	16.80%
LNAI	LUNAI BIOWORKS INC	$14.01M	N/A	-1,617.80%	1,355.58%	749.20%	-2.03	0.19	100.00%	-612,568.10%	-609,894.27%
ARTL	ARTELO BIOSCIENCES INC	$2.54M	-1,602.50%	-225.00%	-195.28%	324.80%	0.88	1.79	N/A	N/A	N/A
RPID	RAPID MICRO BIOSYSTEMS INC	$81.72M	-131.50%	-67.50%	-112.71%	-84.20%	2.06	2.58	2.90%	-145.80%	-141.75%
SYRE	SPYRE THERAPEUTICS INC	$7.71B	-31.20%	-27.80%	-26.43%	-36.20%	0.14	8.97	N/A	N/A	N/A
NAKA	NAKAMOTO INC	$70.30M	-84.80%	-56.50%	-75.51%	-65.40%	0.69	0.25	94.30%	-7,397.80%	-7,110.12%
DNLI	DENALI THERAPEUTICS INC	$4.09B	-52.20%	-43.90%	-43.94%	-54.40%	0.37	9.29	N/A	N/A	N/A
ICCM	ICECURE MEDICAL LTD	$12.47M	-211.70%	-119.10%	-184.54%	-1,142.50%	0.57	2.52	36.50%	-441.60%	-439.94%
RVMD	REVOLUTION MEDICINES INC	$40.39B	-83.20%	-59.10%	-67.98%	-65.20%	0.50	6.80	N/A	N/A	N/A
ENGN	ENGENE THERAPEUTICS INC	$127.95M	-56.10%	-45.60%	-43.39%	-50.00%	0.21	12.57	N/A	N/A	N/A
CLNN	CLENE INC	$76.80M	N/A	-159.10%	-205.21%	-111.30%	-2.15	1.94	82.80%	-25,009.70%	-22,871.64%
ACRV	ACRIVON THERAPEUTICS INC	$76.19M	-64.40%	-57.10%	-79.84%	-89.80%	0.13	8.98	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$313.13M	-181.70%	-119.20%	-175.90%	-430.60%	1.18	5.10	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$9.64M	-411.00%	-275.60%	-661.53%	1,138.50%	0.59	2.68	N/A	N/A	N/A
LRMR	LARIMAR THERAPEUTICS INC	$341.77M	-134.10%	-96.00%	-103.27%	-449.60%	0.32	4.29	N/A	N/A	N/A
ISPC	ISPECIMEN INC	$3.69M	-584.70%	-142.50%	-1,099.45%	244.50%	7.12	0.62	-29.60%	-1,080.70%	-1,080.72%
ONCO	ONCONETIX INC	$1.26M	-109.00%	-51.10%	-77.94%	128.70%	0.26	1.41	79.60%	-1,364.20%	-1,247.44%
CMPX	COMPASS THERAPEUTICS INC	$412.40M	-39.70%	-35.30%	-34.98%	-45.10%	0.10	19.04	N/A	N/A	N/A
NERV	MINERVA NEUROSCIENCES INC	$229.22M	N/A	-662.80%	-463.54%	-601.20%	-1.35	17.65	N/A	N/A	N/A
IMUX	IMMUNIC INC	$202.42M	-220.70%	-132.00%	-68.89%	407.30%	0.26	4.92	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.